1381 |
Coronary Physiology in Severe AS: Decision-Making in TAVR Patients |
Nils Johnson |
Apr. 08. 22 |
1380 |
Vascular Inflammation in Plaque Rupture VS. Plaque Erosion: PCAT Attenuation |
Ik-Kyung Jang |
Apr. 08. 22 |
1379 |
Case #2: PCI with Cre8¢â EVO in DM Patient |
Salvatore Colangelo |
Apr. 08. 22 |
1378 |
Case #1: PCI with Cre8¢â EVO in DM Patient |
Daniel Aradi |
Apr. 08. 22 |
1377 |
Latest Updates on AES Clinical Studies |
Rafael Romaguera |
Apr. 08. 22 |
1376 |
Cre8¢â EVO: Paving the Way for DES Efficacy in Diabetics |
Gennaro Sardella |
Apr. 08. 22 |
1375 |
Lifelong Antiplatelet Therapy After PCI for Prevention of Ischemic Events |
Yongwhi Park |
Apr. 08. 22 |
1374 |
Updated Antiplatelet Approaches for ACS Patients; Tailored DAPT Strategy in De-escalation Era |
So-Yeon Choi |
Apr. 08. 22 |
1373 |
High Bleeding Risk and DAPT Duration – Bifurcation PCI |
Nigel Jepson |
Apr. 08. 22 |
1372 |
Clinical Utility of Telescope¢â Guide Extension for Ostial Calcified Lesion |
Yoshiyasu Minami |
Apr. 08. 22 |